#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sarcoidosis Neonatal alloimmune thrombocytopenia Subdural haematoma Pulmonary arterial hypertension Anti-glomerular basement membrane disease Duchenne muscular dystrophy Pyruvate dehydrogenase complex deficiency Neurodermatitis Chordoma Cold type haemolytic anaemia Piriformis syndrome Chronic granulomatous disease Parkinson's disease Hairy cell leukaemia recurrent Langerhans cell sarcoma More trials…

    Learn about Rare Diseases

    Adrenocortical carcinoma – Diagnostics Usher’s syndrome – Trials in Disease Osteosarcoma – Diagnostics Chronic granulomatous disease – Trials in Disease Krabbe’s disease – Diagnostics Pleomorphic leiomyosarcoma Familial haemophagocytic lymphohistiocytosis – Diagnostics Acute respiratory distress syndrome – Diagnostics Nephrotic syndrome – Life with Disease Angiosarcoma metastatic – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ubiquinol NORETHISTERONE ACETATE Norucholic Acid Reparixin Baclofen Enoxaparin Sodium Cloxacillin Sodium Perindopril Arginine Fludarabine Phosphate Ph. Eur. Sapropterin Dihydrochloride ALN-961583 Ima203Cd8 Timrepigene Emparvovec Gallium (68Ga) Gozetotide Somapacitan VENT-03 Oxcarbazepine ADCE-D01 Bgb-A445 Romosozumab More therapies…

    Learn about Your Condition

    Post procedural hypotension Ewing's sarcoma recurrent Epithelioid sarcoma Neuralgia Hyperphagia Genitourinary tract neoplasm Renal cancer recurrent Inclusion body myositis Dupuytren's contracture Erythema multiforme Anal cancer metastatic Haemofiltration Obsessive-compulsive disorder Thalassaemia Neurogenic bladder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Efficacy and Safety of Givinostat for Non-Ambulant Patients with Duchenne Muscular Dystrophy

    Recruiting

    3 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • Givinostat
    Belgium Czechia France Germany Italy The Netherlands +3

  • Study on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus

    Recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Anhydrous Caffeine
    • Camphor
    • Dapirolizumab Pegol
    Belgium Denmark France Germany Greece Italy +3

  • Study on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Anhydrous Caffeine
    • Camphor
    • Dapirolizumab Pegol
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study on Early Treatment Intensification for Acute Myeloid Leukemia with FLT3 Mutation Using Cytarabine, Midostaurin, and Daunorubicin Hydrochloride for Patients with Low Chemosensitivity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cytarabine
    • Daunorubicin Hydrochloride
    • Midostaurin
    Italy

  • Study on Long-term Effects and Safety of Odevixibat in Children with Biliary Atresia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Congenital absence of bile ducts
    Investigated Drugs:
    • Odevixibat
    Belgium France Germany Hungary Italy The Netherlands +2

  • Study on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Asparaginase
    • Blinatumomab
    • Cyclophosphamide Monohydrate
    Austria Belgium Czechia Denmark Finland France +13

  • Study on Vericiguat for Children with Heart Failure Due to Left Ventricular Systolic Dysfunction

    Recruiting

    4 1
    Investigated Diseases:
    • Chronic left ventricular failure
    Investigated Drugs:
    • Vericiguat
    Belgium Croatia Denmark Finland France Germany +8

  • Study on Atypical Teratoid/Rhabdoid Tumors in Children Using Dactinomycin, Carboplatin, and Cyclophosphamide

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atypical teratoid/rhabdoid tumour of CNS
    Investigated Drugs:
    • Carboplatin
    • Cyclophosphamide
    • Dactinomycin
    Belgium Czechia Denmark Finland France Germany +6

  • Study on the Safety and Effect of EXOB-001 in Preventing Bronchopulmonary Dysplasia in Extremely Preterm Newborns

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    Investigated Drugs:
    • Allogeneic Umbilical Cord Mesenchymal Cells-Derived Extracellular Vesicles
    • Sodium Chloride
    Belgium Italy

  • Safe Discontinuation of Antidepressants in Patients with Remitted Depression: Amitriptyline, Fluoxetine, Paroxetine, and Drug Combination Study

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Amitriptyline Hydrochloride
    • Citalopram Hydrochloride
    • Escitalopram Oxalate
    Italy
Previous Page
1 … 14 15 16 17 18 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!